ifenprodil has been researched along with Encephalopathy, Toxic in 2 studies
ifenprodil: NMDA receptor antagonist
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, Y | 1 |
Shen, W | 1 |
Su, J | 1 |
Cheng, B | 1 |
Li, D | 1 |
Liu, G | 1 |
Zhou, WX | 1 |
Zhang, YX | 1 |
Shin, EJ | 1 |
Nah, SY | 1 |
Chae, JS | 1 |
Bing, G | 1 |
Shin, SW | 1 |
Yen, TP | 1 |
Baek, IH | 1 |
Kim, WK | 1 |
Maurice, T | 1 |
Nabeshima, T | 1 |
Kim, HC | 1 |
2 other studies available for ifenprodil and Encephalopathy, Toxic
Article | Year |
---|---|
Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
Topics: Amyloid beta-Peptides; Animals; Antimetabolites; Cycloserine; Disease Models, Animal; Excitatory Ami | 2017 |
Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Behavior, Animal; Dextromethorphan; Ethyl | 2007 |